Daphne Koller

Founder and CEO of @insitro, Machine Learning pioneer, co-founder of Coursera, adjunct CS Professor at Stanford, avid traveler

[Daphne Koller @DaphneKoller]

I am so excited to welcome Amy to our Board of Directors! Her unique experience in combining technology and data science with drug development and regulatory policy will be invaluable to us as we move to the next phase of our journey at insitro.

[insitro @insitro]

We're thrilled to welcome Dr. Amy Abernethy to our BOD! A clinical research pioneer & hematologist-oncologist, her dedication to data-driven healthcare innovation and transformative drug development on behalf of patients align perfectly with our mission. https://t.co/FsETGqxmLB

[Daphne Koller @DaphneKoller]

Come join our exec team at @insitro - https://t.co/hzFQ5gXWUp: lead our ML efforts and make a difference to patients! We are building an ML-enabled platform to advance medicines for patients in neuroscience, metabolism and oncology diseases. (Read more: https://t.co/R5jicTAU0h).

[Daphne Koller @DaphneKoller]

Excited to welcome Mike to the @insitro team! Mike has an incredible track record of innovation in clinical trial design, to deliver on the goal of accelerating impact to patients. His contributions will be transformative as we enter the next phase of our journey.

[insitro @insitro]

We’re thrilled to welcome Dr. S. Michael Rothenberg as insitro’s CMO. With 2 decades of clinical care & drug development experience, his innovations in data-driven trial design will be critical as we advance our pipeline toward the clinic. https://t.co/jfWC2RUiHC

[Daphne Koller @DaphneKoller]

Thank you @matthewherper for the insightful coverage of our team's scientific progress, highlighting how #AI and #Biology can advance us towards our mission of bringing better medicines to patients. For more details, watch our presentation tomorrow at #jpm2024!

[insitro @insitro]

We’re excited to share @matthewherper’s new story in @statnews, which spotlights 3 new research papers posted online describing exciting developments emerging from our #ML platform across our core therapeutic areas. Read more below. #JPM24

[Daphne Koller @DaphneKoller]

It's been an incredible year for us at insitro, with so much progress on our platform, our science, our team, and our pipeline. And now, to top it off, we are so excited to launch our new website - beautiful yet substantive - which truly tells our differentiated story.

[insitro @insitro]

We're thrilled to launch a new https://t.co/FRy16I4zxE, an immersive portal into our platform, pipeline, science, technology & culture – the intersection of which makes us a company like no other! Check out our teaser video & bookmark us to follow our science, news & progress.

[Daphne Koller @DaphneKoller]

@erichorvitz @insitro Thanks so much, @erichorvitz, for spending the day with us. It was fun to reflect on our early days in #AI and super interesting and inspiring to hear your insights on where the field is today and where it's going!

[Daphne Koller @DaphneKoller]

It was such an honor to have the privilege of interviewing @SueDHellmann as the opening plenary at our invivo week at @insitro. She inspired all of us in our journey to use #MachineLearning towards bringing better medicines, faster to patients who can benefit the most.

[insitro @insitro]

It's go time! #inVivoWeek2023 officially started today at insitro with an incredible, inspiring fireside chat between trailblazing healthcare leader @SueDHellmann and our Founder & CEO @DaphneKoller. Brace yourself for a week of learning, collaboration & boundless #innovation!

[Daphne Koller @DaphneKoller]

@theNASciences I'm honored to be named to the National Academy of Sciences for my contributions to #ML. It's a true privilege to join this esteemed group of scholars. Thank you to the students, mentees, colleagues & collaborators who've supported & inspired me to push the boundaries of ML.

[Daphne Koller @DaphneKoller]

One of the most rewarding aspects of building insitro is our amazing team. I'm thrilled to welcome Philip Tagari, who joins as our inaugural chief scientific officer after serving as a research leader & drug hunter at Amgen for 24 years. Welcome, Philip! https://t.co/eQpZNtesL7

[Daphne Koller @DaphneKoller]

@insitro Incredible culmination of a four-year search to find the right scientific leader for insitro. Deeply excited to partner with Philip on our journey to build a uniquely x-functional company, construct a powerful discovery platform, and deliver transformative medicines for patients.

[Daphne Koller @DaphneKoller]

I am honored to be included in the @Forbes 2022 “50 over 50” list (https://t.co/JeBmXMj2Kh) with incredible women leaders having broad impact across society and industry. It's a privilege to have helped form and build transformative companies @insitro, @coursera, @engageli.

[Daphne Koller @DaphneKoller]

Deeply honored to receive the 2022 Technical Leadership Abie Award from @AnitaB_org this week. I dedicate this award to the incredible young women I've mentored & worked with, including my 2 daughters. May your careers be free of discrimination, allowing your talents to shine!

[Daphne Koller @DaphneKoller]

I'm proud to be the recipient of the 2022 Technical Leadership Abie Award! I look forward to joining the largest gathering of women and non-binary technologists in September as we all strive to transform the future of tech. #GHC22 #NextIsNow #WomenInTech

[Daphne Koller @DaphneKoller]

Redun has greatly eased development of complex pipelines at @insitro and enabled reproducible science. Many thanks to @mattrasmus and team for sharing this important capability with the broader community.

[insitro @insitro]

Thanks to the AWS team for featuring Matt Rasmussen
(@mattrasmus), our VP Software Engineering, in today's HPC blog. We are grateful for the opportunity to continue sharing our excitement about the redun workflow engine we open sourced last year.

[insitro @insitro]

Thanks to the AWS team for featuring Matt Rasmussen
(@mattrasmus), our VP Software Engineering, in today's HPC blog. We are grateful for the opportunity to continue sharing our excitement about the redun workflow engine we open sourced last year.

[Daphne Koller @DaphneKoller]

@insitro @rasmus We are really excited about the ability of redun to enable easier, more reproducible science. Thanks to Matt and team for this important contribution to the community!

[Daphne Koller @DaphneKoller]

@insitro I'm deeply honored at this recognition, joining a group of remarkable former winners of this award. I would like to thank my many trainees and other collaborators for their critical contributions to our joint work that is being recognized here!

[insitro @insitro]

#AI in drug discovery has incredible potential, but it remains hard and some of the hype may not be grounded in reality. Our CEO and founder @DaphneKoller spoke with @MaxGelman about why she believes the industry needs to calibrate people's expectations with what's possible.

[Daphne Koller @DaphneKoller]

@insitro @statnews Honored to be included in this list alongside some incredible leaders.

[Daphne Koller @DaphneKoller]

Excited to share redun with data scientists everywhere. We hope redun will help democratize data science at scale, and support robust, reproducible science.

[insitro @insitro]

We're excited to announce the open sourcing of redun, an expressive, efficient, and easy-to-use workflow framework designed to deal with complex, rapidly evolving scientific workflows spanning multiple data types. Read more here: https://t.co/kwuMOrpI01